Pages that link to "Q37470906"
Jump to navigation
Jump to search
The following pages link to TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia (Q37470906):
Displaying 50 items.
- Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation (Q24311603) (← links)
- The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural development (Q26739014) (← links)
- Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy (Q26749870) (← links)
- New answers to old questions from genome-wide maps of DNA methylation in hematopoietic cells (Q26851510) (← links)
- Connections between TET proteins and aberrant DNA modification in cancer (Q26865671) (← links)
- Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 (Q27687464) (← links)
- TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study (Q27851621) (← links)
- Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia (Q28236628) (← links)
- Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia (Q28307278) (← links)
- Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies (Q28591763) (← links)
- SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML) (Q30420638) (← links)
- Applicability of next-generation sequencing to decalcified formalin-fixed and paraffin-embedded chronic myelomonocytic leukaemia samples (Q33583033) (← links)
- The role of mutations in epigenetic regulators in myeloid malignancies (Q34033164) (← links)
- New clues to the molecular pathogenesis of myelodysplastic syndromes (Q34102690) (← links)
- Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms (Q34302770) (← links)
- Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms (Q34417810) (← links)
- Cytogenetic risk stratification in chronic myelomonocytic leukemia. (Q34612592) (← links)
- Concise review: preleukemic stem cells: molecular biology and clinical implications of the precursors to leukemia stem cells (Q34647637) (← links)
- Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia (Q34700714) (← links)
- TET proteins and the control of cytosine demethylation in cancer (Q35021377) (← links)
- TET2 mutations in secondary acute myeloid leukemias: a French retrospective study (Q35082536) (← links)
- Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapy (Q35132953) (← links)
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. (Q35346433) (← links)
- Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis (Q35575250) (← links)
- TET family proteins and their role in stem cell differentiation and transformation. (Q35630033) (← links)
- Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors (Q35797589) (← links)
- TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia. (Q35862540) (← links)
- Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia (Q35911141) (← links)
- Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia. (Q36179524) (← links)
- Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host (Q36257990) (← links)
- Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia (Q36498395) (← links)
- Digging deep into "dirty" drugs - modulation of the methylation machinery (Q36523796) (← links)
- Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia (Q36548070) (← links)
- Chronic myelomonocytic leukemia: Forefront of the field in 2015. (Q36876853) (← links)
- AF9 promotes hESC neural differentiation through recruiting TET2 to neurodevelopmental gene loci for methylcytosine hydroxylation. (Q36882821) (← links)
- TET2 mutations in Ph-negative myeloproliferative neoplasms: identification of three novel mutations and relationship with clinical and laboratory findings. (Q36916115) (← links)
- Alterations of 5-hydroxymethylcytosine in human cancers (Q37226486) (← links)
- Age-related mutations and chronic myelomonocytic leukemia. (Q37395779) (← links)
- Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features (Q37636744) (← links)
- Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes (Q37671806) (← links)
- Epigenetic regulation in myelodysplastic syndromes: implications for therapy (Q37850456) (← links)
- Transcriptional and epigenetic networks in haematological malignancy (Q37863271) (← links)
- Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions (Q37979958) (← links)
- Heterogeneity of molecular markers in chronic myelomonocytic leukemia: a disease associated with several gene alterations. (Q37993420) (← links)
- Epigenetic aspects of MDS and its molecular targeted therapy (Q38051195) (← links)
- Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia (Q38129336) (← links)
- Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups (Q38134374) (← links)
- Genome-scale technology driven advances to research into normal and malignant haematopoiesis (Q38166364) (← links)
- Epigenetic deregulation in myeloid malignancies. (Q38210621) (← links)
- Genomic characterization of acute leukemias (Q38223490) (← links)